Bolt Biotherapeutics, Inc. - Form 4 Filing

This filing details a series of stock sales by Yonehiro Grant, Chief Operating Officer of Bolt Biotherapeutics, Inc. On September 16, 2026, Mr. Grant sold 1417 shares of Common Stock at a weighted average price of $3.774 to cover tax obligations related to vested restricted stock units. Following this transaction, he owned 29028 shares. On September 17, 2026, he sold 4909 shares at a weighted average price of $3.3183, reducing his holdings to 24119 shares. On September 18, 2026, an additional 6850 shares were sold at a weighted average price of $3.2364, leaving him with 17269 shares. These sales were made to cover tax withholding obligations in connection with the vesting of restricted stock units granted on October 22, 2025. Specific price ranges for these transactions are available upon request from the SEC, the Issuer, or security holders.